These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 38999840)

  • 21. Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity.
    Joo M; Nam S
    BMC Microbiol; 2024 Jul; 24(1):268. PubMed ID: 39030520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
    Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
    Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
    Pittayanon R; Lau JT; Leontiadis GI; Tse F; Yuan Y; Surette M; Moayyedi P
    Gastroenterology; 2020 Mar; 158(4):930-946.e1. PubMed ID: 31812509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
    Hu Y; Chen Z; Xu C; Kan S; Chen D
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases.
    Scarpato E; Russo M; Staiano A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S7-S9. PubMed ID: 30036240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
    Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of the gut microbiota and its application in inflammatory bowel disease.
    Wang X; Peng J; Cai P; Xia Y; Yi C; Shang A; Akanyibah FA; Mao F
    Biomed Pharmacother; 2024 Oct; 179():117302. PubMed ID: 39163678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between intestinal microbiota and inflammatory bowel disease.
    Zhang Y; Si X; Yang L; Wang H; Sun Y; Liu N
    Animal Model Exp Med; 2022 Dec; 5(4):311-322. PubMed ID: 35808814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
    Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease.
    Maronek M; Link R; Ambro L; Gardlik R
    Cells; 2020 Apr; 9(4):. PubMed ID: 32325706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
    Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
    Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future.
    Oliveira ECS; Quaglio AEV; Magro DO; Di Stasi LC; Sassaki LY
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
    Schultz M; Schölmerich J; Rath HC
    Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.
    Shapiro JM; de Zoete MR; Palm NW; Laenen Y; Bright R; Mallette M; Bu K; Bielecka AA; Xu F; Hurtado-Lorenzo A; Shah SA; Cho JH; LeLeiko NS; Sands BE; Flavell RA; Clemente JC
    Cell Host Microbe; 2021 Jan; 29(1):83-93.e3. PubMed ID: 33385335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.